Conexeu Sciences is trading at $3.19, up 6.52%, with broader biotech strength offering context; no verified company-specific announcement explains the October 21 move.
- Biotech ETF XBI rose 2.10% during the regular session, alongside biotech M&A activity and positive clinical-trial news. This supports a sector-related explanation, not a confirmed company catalyst.
- The latest company news found was an October 15 private placement.
- Trading volume was about 597,000 shares, versus average daily volume of about 496,000.